Component

Mouse-cell amino acid response during halofuginone exposure

Context-specific entity; species, compartment and exposure are stated on each claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Exogenous proline reversed halofuginone-induced amino-acid response signaling and selected cellular effects in the study, consistent with competition at the prolyl-tRNA synthetase step.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_access
    Primary full text
    experimental_model
    Mouse embryonic fibroblast and immune-cell experiments with halofuginone; model and assay-specific concentrations.
    limitations
    Not every proline-processing defect is competitively reversible, and this is not a clinical drug-interaction dose recommendation.
    nutrient_topic
    L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
    plain_language
    Restoring access to a blocked loading step can turn off a shortage-like signal.
    primary_references
    Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22327401/ · DOI 10.1038/nchembio.790
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 238–244

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse embryonic fibroblast and immune-cell experiments with halofuginone; model and assay-specific concentrations. · source_derived_draft · unverified_draft

    ## l-proline-eprs-stress-rescue Restoring access to a blocked loading step can turn off a shortage-like signal. Exogenous proline reversed halofuginone-induced amino-acid response signaling and selected cellular effects in the study, consistent with competition at the prolyl-tRNA synthetase step. Model: Mouse embryonic fibroblast and immune-cell experiments with halofuginone; model and assay-specific concentrations. Limitations: Not every proline-processing defect is competitively reversible, and this is not a clinical drug-interaction dose recommendation. Evidence access: Primary full text Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22327401/ · DOI 10.1038/nchembio.790
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards